Orchestra BioMed Holdings, Inc. (OBIO) Earnings

Orchestra BioMed Holdings, Inc. is expected to report next earnings on August 11, 2026 (in NaN days), with a consensus EPS estimate of $-0.35. OBIO has beaten EPS estimates in 7 of its last 9 reported quarters (average surprise +47.1% over the last four).

Next earnings
Aug 11, 2026in NaN days
EPS est $-0.35 · Revenue est $144143
Track record
Beat EPS in 7 of 9 quarters
Avg surprise +47.1% (last 4 quarters)
Earnings history
Report dateEPS estEPS actualSurpriseRevenueRev. surprise
May 12, 2026$-0.40$-0.33+17.5%$110000-88.0%
Mar 12, 2026$-0.38$0.26+168.8%$31M+3220.8%
Aug 12, 2025$-0.51$-0.50+2.0%$836000+7.3%
Apr 2, 2025$-0.43$-0.43+0.0%$253000-51.6%
Mar 26, 2025$-0.43$-0.37+14.0%$253000
Nov 13, 2023$-0.39$-0.38+2.6%$419000-53.2%
Aug 10, 2023$-0.42$-0.35+16.7%$915000+29.6%
May 12, 2023$-0.28$-0.40-42.9%$1M+71.2%
Jan 24, 2023$-0.43$-0.08+81.8%$1M+55.4%
Dec 16, 2022$-0.05$1M
Mar 31, 2022$-0.18$866000

Source: company filings + earnings calendar. For informational purposes only — not investment advice.